Biodesix (BDSX) Total Non-Current Liabilities (2019 - 2026)

Biodesix has reported Total Non-Current Liabilities for 8 years, with the latest figure at $71.0 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities rose 14.79% year-over-year to $71.0 million; the trailing twelve-month figure through Mar 2026 stood at $71.0 million (up 14.79% YoY), and the FY2025 full-year result was $72.5 million, up 16.85% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $71.0 million, down from $72.5 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $72.5 million in Q4 2025, with the low at $24.1 million in Q1 2022.
• Historically, Total Non-Current Liabilities has averaged $56.5 million across 5 years, with a median of $61.5 million in 2024.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities sank 61.77% — and 2023, when it jumped 125.05%.
• Biodesix's Total Non-Current Liabilities stood at $49.5 million in 2022, then climbed by 23.53% to $61.1 million in 2023, then climbed by 1.56% to $62.1 million in 2024, then climbed by 16.85% to $72.5 million in 2025, then decreased by 2.05% to $71.0 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $71.0 million (Q1 2026), $72.5 million (Q4 2025), and $72.3 million (Q3 2025), per Business Quant data.